# A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees

> **NCT01925261** · PHASE2 · COMPLETED · sponsor: **OrthoTrophix, Inc** · enrollment: 120 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** TPX-100 50mg
- **DRUG:** TPX-100 100mg
- **DRUG:** TPX-100 200mg
- **DRUG:** TPX-100 20mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01925261
- **Lead sponsor:** OrthoTrophix, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2017-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01925261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01925261, "A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01925261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*